skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 27,180  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: Database: Springer Nature OA/Free Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
Material Type:
Article 		Add to My Research

COVID-19 vaccines for patients with cancer: benefits likely outweigh risks

Journal of hematology and oncology, 2021-02, Vol.14 (1), p.38-11, Article 38 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-021-01046-w ;PMID: 33640005

Full text available

Citations Cited by
2
Recovering Civility during COVID-19
Recovering Civility during COVID-19
Material Type:
Book 		Add to My Research

Recovering Civility during COVID-19

ISBN: 9789813367067 ;ISBN: 9813367067 ;ISBN: 9813367059 ;ISBN: 9789813367050 ;EISBN: 9789813367067 ;EISBN: 9813367067 ;DOI: 10.1007/978-981-33-6706-7 ;OCLC: 1249470850

Full text available

Citations Cited by
3
Detection technologies and recent developments in the diagnosis of COVID-19 infection
Detection technologies and recent developments in the diagnosis of COVID-19 infection
Material Type:
Article 		Add to My Research

Detection technologies and recent developments in the diagnosis of COVID-19 infection

Applied microbiology and biotechnology, 2021, Vol.105 (2), p.441-455 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021. ;ISSN: 0175-7598 ;EISSN: 1432-0614 ;DOI: 10.1007/s00253-020-11061-5 ;PMID: 33394144

Full text available

Citations Cited by
4
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Material Type:
Article 		Add to My Research

Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19

The AAPS journal, 2021-01, Vol.23 (1), p.14, Article 14 [Peer Reviewed Journal]

The Author(s) 2021 ;ISSN: 1550-7416 ;EISSN: 1550-7416 ;DOI: 10.1208/s12248-020-00532-2 ;PMID: 33400058

Full text available

Citations Cited by
5
Coronavirus vaccine development: from SARS and MERS to COVID-19
Coronavirus vaccine development: from SARS and MERS to COVID-19
Material Type:
Article 		Add to My Research

Coronavirus vaccine development: from SARS and MERS to COVID-19

Journal of biomedical science, 2020-12, Vol.27 (1), p.104-104, Article 104 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1423-0127 ;ISSN: 1021-7770 ;EISSN: 1423-0127 ;DOI: 10.1186/s12929-020-00695-2 ;PMID: 33341119

Full text available

Citations Cited by
6
mRNA vaccine for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Material Type:
Article 		Add to My Research

mRNA vaccine for cancer immunotherapy

Molecular cancer, 2021-02, Vol.20 (1), p.41-41, Article 41 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-021-01335-5 ;PMID: 33632261

Full text available

Citations Cited by
7
COVID-19: breaking down a global health crisis
COVID-19: breaking down a global health crisis
Material Type:
Article 		Add to My Research

COVID-19: breaking down a global health crisis

Annals of clinical microbiology and antimicrobials, 2021-05, Vol.20 (1), p.35-35, Article 35 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1476-0711 ;EISSN: 1476-0711 ;DOI: 10.1186/s12941-021-00438-7 ;PMID: 34006330

Full text available

Citations Cited by
8
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Material Type:
Article 		Add to My Research

Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development

Virology journal, 2024-04, Vol.21 (1), p.98-98 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1743-422X ;EISSN: 1743-422X ;DOI: 10.1186/s12985-024-02370-6 ;PMID: 38671455

Full text available

Citations Cited by
9
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method
Material Type:
Article 		Add to My Research

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method

Critical care (London, England), 2021-03, Vol.25 (1), p.106-106, Article 106 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2021 ;ISSN: 1364-8535 ;EISSN: 1466-609X ;DOI: 10.1186/s13054-021-03491-y ;PMID: 33726819

Full text available

Citations Cited by
10
Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis

Journal of hematology and oncology, 2022-02, Vol.15 (1), p.15-15, Article 15 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-022-01233-3 ;PMID: 35123511

Full text available

Citations Cited by
11
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription
Material Type:
Article 		Add to My Research

SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription

Genome medicine, 2021-03, Vol.13 (1), p.43-17, Article 43 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1756-994X ;EISSN: 1756-994X ;DOI: 10.1186/s13073-021-00859-1 ;PMID: 33722288

Full text available

Citations Cited by
12
Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction
Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction
Material Type:
Article 		Add to My Research

Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction

Respiratory research, 2024-05, Vol.25 (1), p.209-209 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-024-02830-1 ;PMID: 38750527

Full text available

Citations Cited by
13
SARS coronavirus 2: from genome to infectome
SARS coronavirus 2: from genome to infectome
Material Type:
Article 		Add to My Research

SARS coronavirus 2: from genome to infectome

Respiratory research, 2020-12, Vol.21 (1), p.318-15, Article 318 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-020-01581-z ;PMID: 33261606

Full text available

Citations Cited by
14
COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
Material Type:
Article 		Add to My Research

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy

Human genomics, 2021-05, Vol.15 (1), p.27-13, Article 27 [Peer Reviewed Journal]

2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1479-7364 ;ISSN: 1473-9542 ;EISSN: 1479-7364 ;DOI: 10.1186/s40246-021-00326-3 ;PMID: 33966626

Full text available

Citations Cited by
15
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
Material Type:
Article 		Add to My Research

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

Journal of neurovirology, 2021-02, Vol.27 (1), p.191-195 [Peer Reviewed Journal]

The Author(s) 2021 ;ISSN: 1355-0284 ;EISSN: 1538-2443 ;DOI: 10.1007/s13365-021-00954-4

Digital Resources/Online E-Resources

Citations Cited by
16
Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services
Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services
Material Type:
Article 		Add to My Research

Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services

BMC health services research, 2020-12, Vol.20 (1), p.1144-1144, Article 1144 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/s12913-020-06001-y ;PMID: 33342437

Full text available

Citations Cited by
17
COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa
COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa
Material Type:
Article 		Add to My Research

COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa

Globalization and health, 2021-03, Vol.17 (1), p.24-24, Article 24 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1744-8603 ;EISSN: 1744-8603 ;DOI: 10.1186/s12992-021-00668-6 ;PMID: 33658050

Full text available

Citations Cited by
18
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
Material Type:
Article 		Add to My Research

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Current controlled trials in cardiovascular medicine, 2020-11, Vol.21 (1), p.981-981, Article 981 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1745-6215 ;EISSN: 1745-6215 ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-020-04876-0 ;PMID: 33246499

Full text available

Citations Cited by
19
Long COVID in pediatrics—epidemiology, diagnosis, and management
Long COVID in pediatrics—epidemiology, diagnosis, and management
Material Type:
Article 		Add to My Research

Long COVID in pediatrics—epidemiology, diagnosis, and management

European journal of pediatrics, 2024-04, Vol.183 (4), p.1543-1553 [Peer Reviewed Journal]

The Author(s) 2024 ;EISSN: 1432-1076 ;DOI: 10.1007/s00431-023-05360-y

Digital Resources/Online E-Resources

Citations Cited by
20
Predictors of willingness to get a COVID-19 vaccine in the U.S
Predictors of willingness to get a COVID-19 vaccine in the U.S
Material Type:
Article 		Add to My Research

Predictors of willingness to get a COVID-19 vaccine in the U.S

BMC infectious diseases, 2021-04, Vol.21 (1), p.338-338, Article 338 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2334 ;EISSN: 1471-2334 ;DOI: 10.1186/s12879-021-06023-9 ;PMID: 33845781

Full text available

Citations Cited by

Results 1 - 20 of 27,180  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (26,709)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2014  (1)
  2. 2014 To 2016  (1)
  3. 2017 To 2017  (1)
  4. 2018 To 2020  (3,174)
  5. After 2020  (23,997)
  6. More options open sub menu

Language 

  1. English  (26,891)
  2. Japanese  (1,232)
  3. German  (481)
  4. Portuguese  (36)
  5. Norwegian  (25)
  6. Dutch  (20)
  7. Italian  (4)
  8. Korean  (1)
  9. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait